Scientists hope to give people back the use of disabled arms and legs after a world-first breakthrough allowing them to regrow the missing nerves in rats.
Trials of the technology are still in the early stages, but better-than-expected results raise prospects of saving limbs lost in accidents or eventually overcoming paraplegia and quadriplegia.
St Vincent’s Hospital researchers have built and implanted a bridge between severed nerves in areas too large and complex to be healed by conventional nerve grafts.
After successfully restoring the feeling and partial use of legs in rats missing the main nerve to their limbs, director of neurosciences Prof Mark Cook said new trials had begun to see how far the technology can allow nerves to regrow in the hope it can be expanded to humans studies in the next two to five years.
“We will have the potential to deal with a broader range and bigger injured nerves down the track,” Prof Cook said.
“Some of these gaps in humans are substantial. You can have long sections of nerves in humans because obviously their limbs are a lot longer than in animals such as rats.
“We started by focusing on the large peripheral nerves as it seems the best target and, once we have mastered that, we would be able to move on to the spinal chord. This worked better than we anticipated so we are really pleased it is something we can take to humans in the not-too-distant future.”
In conjunction with ARC Centre of Excellence for Electromaterials Science in Wollongong, the St Vincent’s team built a chamber made of polymer and containing a gel of growth factors, which is placed in a 1cm section of missing nerve to act as a bridge and restore contact between the brain and damaged sections of the body.
In recent trials the scientists were able to see rats regain partial and, when the chambers were removed after four weeks, discovered new nerves had grown to reconnect the disabled limbs to the brain.
Assoc Prof Robert Kapsa said the technology could mitigate the impact of injuries by restoring more feeling.
Go deeper with Bing News on:
- New therapeutic approach enables functional recovery after spinal cord injury in miceon January 16, 2021 at 11:12 am
Using gene therapy, a research team has succeeded for the first time in getting mice to walk again after a complete cross-sectional injury. The nerve cells produced the curative protein themselves.
- Paralyzed Mice Walk Again after Treatment with Designer Cytokineon January 15, 2021 at 3:30 pm
In mice, loss of hindlimb motion due to spinal cord injury was significantly reversed by DNA encoding hyper-interleukin-6 (hIL-6), a designer cytokine. The DNA was delivered by an adeno-associated ...
- Designer cytokine makes paralyzed mice walk againon January 15, 2021 at 9:27 am
To date, paralysis resulting from spinal cord damage has been irreparable. With a new therapeutic approach, scientists from the Department for Cell Physiology at Ruhr-Universität Bochum (RUB) headed ...
- A rift in the retina may help repair the optic nerveon January 14, 2021 at 7:49 am
In experiments in mouse tissues and human cells, Johns Hopkins Medicine researchers say they have found that removing a membrane that lines the back of the eye may improve the success rate for ...
- Nerve Regeneration Market 2020 Global Growth Opportunities, Key Driving Factors, Industry Scenario and Forecast to 2024on January 12, 2021 at 4:21 pm
Global Nerve Regeneration Market is expected to register a CAGR of 11.34% to reach USD 12695.25 million by 2024.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- IU School of Medicine Offers New Program for Innovative Health Careon January 12, 2021 at 4:22 pm
Indiana University School of Medicine launched a new PhD program to train the next generation on a new dimension of health care.
- Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allografton January 12, 2021 at 10:43 am
Direct Biologics, LLC, an industry leader in extracellular vesicle technology, announced today that the company has launched AmnioWrap™ placental-based sheet allografts for clinical use. AmnioWrap™ is ...
- Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For ...on January 12, 2021 at 1:43 am
RMAT Designation Enables Closer FDA Interactions to Support Accelerated Approval CANTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative ...
- Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Kneeon January 11, 2021 at 12:01 am
FDA Determines ReNu Preliminary Clinical Evidence Indicates Potential to Address Unmet Medical Needs for the Management of Symptoms Associated with Knee Osteoarthritis. RMAT Desig ...
- Regenerative Medicine Market to Reach Valuation US$ 23.7 Bn by 2027on January 8, 2021 at 9:55 am
The global regenerative medicine market is representing impressive CAGR of 16.1% during the forecast period 2020 to 2027. Regenerative medicine is the division of medicine that promotes methods to ...